Quantifying the Benefits of Targeting for Pandemic Response
Sergio Camelo, View ORCID ProfileFlorin Ciocan, View ORCID ProfileDan A. Iancu, View ORCID ProfileXavier S. Warnes, View ORCID ProfileSpyros I. Zoumpoulis
doi: https://doi.org/10.1101/2021.03.23.21254155
Sergio Camelo
1Institute for Computational and Mathematical Engineering, Stanford University
Florin Ciocan
2Technology and Operations Management, INSEAD
Dan A. Iancu
3Technology and Operations Management, INSEAD and Operations, Information & Technology, Graduate School of Business, Stanford University
Xavier S. Warnes
4Operations, Information & Technology, Graduate School of Business, Stanford University
Spyros I. Zoumpoulis
5Decision Sciences, INSEAD
Article usage
Posted December 15, 2021.
Quantifying the Benefits of Targeting for Pandemic Response
Sergio Camelo, Florin Ciocan, Dan A. Iancu, Xavier S. Warnes, Spyros I. Zoumpoulis
medRxiv 2021.03.23.21254155; doi: https://doi.org/10.1101/2021.03.23.21254155
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (716)
- Anesthesia (210)
- Cardiovascular Medicine (2992)
- Dermatology (254)
- Emergency Medicine (447)
- Epidemiology (12881)
- Forensic Medicine (12)
- Gastroenterology (840)
- Genetic and Genomic Medicine (4677)
- Geriatric Medicine (428)
- Health Economics (737)
- Health Informatics (2974)
- Health Policy (1079)
- Hematology (396)
- HIV/AIDS (942)
- Medical Education (434)
- Medical Ethics (116)
- Nephrology (479)
- Neurology (4457)
- Nursing (239)
- Nutrition (654)
- Oncology (2319)
- Ophthalmology (659)
- Orthopedics (261)
- Otolaryngology (330)
- Pain Medicine (289)
- Palliative Medicine (85)
- Pathology (506)
- Pediatrics (1208)
- Primary Care Research (506)
- Public and Global Health (7055)
- Radiology and Imaging (1565)
- Respiratory Medicine (927)
- Rheumatology (447)
- Sports Medicine (389)
- Surgery (495)
- Toxicology (60)
- Transplantation (214)
- Urology (186)